StockTipsArenaBeta

SELL Dr. Reddy's Laboratories Limited — Emkay Global

SELLDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byEmkay GlobalHorizon: NA (inferred 1 year)1 Jul 2026via Institutional / Brokerage Research

Entry₹1,339.9Inferred
Target₹1,300
Total upside +2.98% (call closed)
Stop lossNot given
Exit₹1,3009 Jul 2026, 12:07 pm
Target hit+2.98%0.00%upside left
Follow Emkay Global for new calls(64% target hit, 377 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 19 active Long-term calls on DRREDDYSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:48 pm IST
1 supporting4 opposing
Supports the SELL call (1)

3 other SEBI-registered advisors have active long-term SELL calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·9 Jul · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the SELL call (4)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·29 Jun · 1w ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·22 Jun · 2w ago

Dr. Reddy's Laboratories Limited announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States.

NSE · Press Release·13 Jun · 4w ago

(opens in new tab)

Dr. Reddy's Laboratories Ltd. has launched Bosutinib Tablets 400mg.

BSE · Company Update·13 Jun · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Emkay Global

Every call and its outcome